Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
Biogen discontinues all AAV gene therapy work
While most of the team members that had focused on AAV capsids were reassigned to other roles, a small number of employees were laid off.
Gabrielle Masson
Sep 26, 2025 11:04am
Fierce Pharma
GSK plots $30B investment in US manufacturing, R&D
Sep 16, 2025 7:01pm
AZ pauses $271M UK expansion as British backtrack continues
Sep 12, 2025 2:44pm
Eli Lilly reconsiders UK biotech incubator
Sep 12, 2025 12:09pm
ABPI releases life sci competition report as UK investment lags
Sep 10, 2025 5:30pm
Merck scraps £1B project, along with all R&D operations in UK
Sep 10, 2025 3:40pm
